Wolfe Research reiterates CoreWeave stock Outperform rating at $150

Wolfe Research reiterated an Outperform rating and a $150 price target on CoreWeave (CRWV), implying ~77% upside from $81.75. The firm slightly raised its fiscal 2026 capex estimate above the top end of guidance, citing a higher Q3 mix and increased capacity investment, while keeping operating income and revenue estimates unchanged. Wolfe expects Q2 to be the largest quarter for active power added, with backlog at ~$110B-$115B (below some $125B-$130B expectations) and sees fiscal 2026 backlog ending >$135B, supporting higher fiscal 2027 recurring revenue.

Analysis

The market is treating this like a capacity compounder, but the second-order issue is balance-sheet translation: incremental capex only helps the equity if it converts into higher-quality backlog and not just a larger asset base with still-negative earnings power. With the stock already re-rated aggressively, the valuation setup is now much more sensitive to any hiccup in power delivery, component costs, or customer concentration than to the next analyst upgrade.

The near-term winner is the AI infrastructure supply chain, not necessarily the platform name itself. Names with exposure to racks, power, networking, and GPUs should keep seeing demand pull-forward, while peers that also rely on external cloud capacity may face a tougher pricing environment if large customers build more in-house optionality. Meta is the key strategic overhang: even a limited push into cloud services signals that the largest buyers want more control over the stack, which caps the long-run scarcity premium embedded in outsourced AI compute.

The contrarian miss is that the relevant metric is not backlog size in isolation; it is backlog versus committed capex and the implied return on invested capital over 12-24 months. If the next few quarters show backlog growth lagging capacity additions, the multiple can compress fast even without a revenue miss. Conversely, a clean execution print with accelerating backlog and no component inflation would force the shorts to cover because the stock is still trading as if scarcity lasts forever.

Key Decisions for Investors

• Tactically short CRWV on further strength or via a 1-3 month put spread; the risk/reward favors fading a 25x+ EBITDA name if backlog growth remains below the market's highest expectations. Invalidated if the next update shows backlog >$125B and no deterioration in power-add timing or margins.
• Pair trade: long META / short CRWV over the next 1-3 months. META has the balance sheet to internalize AI/cloud economics, while CRWV is more exposed to capex intensity and re-rating risk if hyperscalers reduce outsourcing dependence.
• Relative value: long VRT or ETN against short CRWV for 6-12 months. The thesis is that infrastructure suppliers capture the AI capex wave with less execution and financing risk than an asset-heavy compute lessor.
• Avoid chasing CRWV ahead of the next operating update; wait for a pullback or a post-print setup. If the stock holds current levels despite a backlog disappointment, that would signal momentum is overpowering fundamentals and the short should be reduced.